A detailed history of Royal Bank Of Canada transactions in Astrazeneca PLC stock. As of the latest transaction made, Royal Bank Of Canada holds 2,439,535 shares of AZN stock, worth $184 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,439,535
Previous 2,399,321 1.68%
Holding current value
$184 Million
Previous $163 Million 17.04%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $2.69 Million - $3.25 Million
40,214 Added 1.68%
2,439,535 $190 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $2.97 Million - $3.39 Million
48,695 Added 2.07%
2,399,321 $163 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $2.87 Million - $3.22 Million
46,433 Added 2.02%
2,350,626 $158 Million
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $4.4 Million - $4.86 Million
67,843 Added 3.03%
2,304,193 $156 Million
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $4.04 Million - $4.38 Million
-57,826 Reduced 2.52%
2,236,350 $160 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $10.3 Million - $11.7 Million
163,722 Added 7.68%
2,294,176 $159 Million
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $11.1 Million - $14.4 Million
-203,916 Reduced 8.74%
2,130,454 $144 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $2.33 Million - $5.98 Million
-44,039 Reduced 1.85%
2,334,370 $128 Million
Q2 2022

Aug 15, 2022

SELL
$59.26 - $71.14 $1.75 Million - $2.11 Million
-29,591 Reduced 1.23%
2,378,409 $157 Million
Q1 2022

May 16, 2022

SELL
$55.72 - $67.12 $3.13 Million - $3.77 Million
-56,222 Reduced 2.28%
2,408,000 $160 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $2.98 Million - $3.52 Million
-55,103 Reduced 2.19%
2,464,222 $144 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $30.3 Million - $33.2 Million
545,462 Added 27.63%
2,519,325 $151 Million
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $95.6 Million - $119 Million
1,973,863 New
1,973,863 $118 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.